Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Aberrations
9%
Acute Leukemia
20%
Acute Lymphoblastic Leukemia
100%
Acute Megakaryoblastic Leukemia
17%
Acute Myeloid Leukemia
11%
AIEOP
12%
Atropine
9%
B-cell Acute Lymphoblastic Leukemia (B-ALL)
12%
BCP-ALL
21%
Berlin
14%
Cancer Cells
18%
Central Nervous System
10%
Childhood Acute Lymphoblastic Leukemia
54%
Childhood Leukemia
17%
Children with Down Syndrome
13%
Chromosome 21
13%
Cytokine Receptor-like Factor 2
9%
Down Syndrome
59%
Event-free Survival
9%
Frankfurt
11%
GATA1
14%
Gene Expression
13%
Gene Expression Profile
9%
Germline
11%
Hematological Malignancies
9%
Hematopoietic Stem Cells
13%
High Risk
18%
Interleukin-7 Receptor
9%
Israel
13%
Israeli
10%
Janus Kinase 2 (JAK2)
8%
Leukemia
81%
Leukemia Patients
14%
Leukemic Cells
16%
Leukemogenesis
11%
Minimal Residual Disease
17%
Mitosis
8%
Overexpression
13%
Pediatric
11%
Pediatric Acute Lymphoblastic Leukemia
11%
Pediatric Patients
18%
Poor Prognosis
13%
Risk Factors
8%
Risk Stratification
9%
Somatic mutation
9%
STILs
14%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
14%
Trisomy 21
18%
Tumor
11%
Working Diagnosis
8%
Biochemistry, Genetics and Molecular Biology
Aneuploidy
10%
B Cell
33%
Cancer Cell
14%
Carcinogenesis
7%
Centriole
5%
Centrosome
9%
Chromosomal Rearrangement
6%
Chromosome
8%
Chromosome 21
8%
Cytogenetics
7%
Cytokine Receptor
12%
Down Syndrome
38%
Enhancer Region
7%
ETV6
11%
Event Free Survival
6%
Fluorescence in Situ Hybridization
5%
Fusion Gene
6%
GATA1
7%
GATA2
5%
Gene Expression
19%
Gene Expression Profiling
9%
Genetics
27%
Genomics
15%
Germ Cell
10%
Germline
6%
Hedgehog Signaling Pathway
7%
Hematopoietic Cell
13%
Janus Kinase
6%
Kinase
6%
Messenger RNA
6%
MicroRNA
11%
Mitosis
9%
Myeloid
23%
Oncogene
5%
PBX1
6%
Pediatrics
32%
Phosphotransferase
6%
Polymerase Chain Reaction
5%
Precursor
26%
Promoter Region
5%
RUNX1
6%
Somatic Mutation
6%
Spindle Checkpoint
5%
Stem Cell
7%
STIL
14%
T Cell
6%
TAL1
6%
Targeted Therapy
5%
Transcription Factors
9%
Trisomy 21
8%
Medicine and Dentistry
Acute Leukemia
6%
Acute Lymphoblastic Leukemia
66%
Acute Lymphocytic Leukemia
13%
Acute Megakaryoblastic Leukemia
9%
Acute Myeloid Leukemia
7%
Adolescence
6%
B Cell
9%
Cancer
8%
Chemotherapy
7%
Childhood Leukemia
12%
Cytokine Receptor
6%
Diseases
14%
Down Syndrome
37%
Event Free Survival
8%
Gene Expression
5%
Genetics
12%
Hematologic Malignancy
8%
Infection
10%
Leukemia
51%
Leukemia in Children
8%
Leukemogenesis
5%
Lymphoid Leukemia
5%
Malignant Neoplasm
15%
Minimal Residual Disease
9%
Myelodysplastic Syndrome
6%
Neoplasm
7%
Non Small Cell Lung Cancer
7%
Overall Survival
5%
Pathogenesis
6%
Pediatrics
24%
Pediatrics Patient
5%
Precursor
11%
Risk Stratification
6%
Sepsis
6%
Somatics
12%
Transcription Factor GATA 1
12%
Trisomy 21
13%
